NeuroSense Therapeutics Ltd. - NRSN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$259K
QoQ value delta ($000)
-$85K (-24.71%)
Implied price effect (QoQ)
-39.55%
Shares
Total shares
346,134
QoQ shares delta
+68,209 (+24.54%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NRSN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 12 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Yorkville Advisors Global, LP 76 100,000 0.05%
TWO SIGMA INVESTMENTS, LP 39 51,545 0.0%
MEITAV INVESTMENT HOUSE LTD 30 40,000 0.0%
GTS SECURITIES LLC 27 35,753 0.0%
UBS Group AG 23 30,871 0.0%
COMMONWEALTH EQUITY SERVICES, LLC 17 22,775 0.0%
Squarepoint Ops LLC 13 17,926 0.0%
GEODE CAPITAL MANAGEMENT, LLC 12 15,870 0.0%
Pathstone Holdings, LLC 12 16,528 0.0%
Creative Planning 9 11,911 0.0%
SBI Securities Co., Ltd. 1 1,455 0.0%
JONES FINANCIAL COMPANIES LLLP 0 1,000 0.0%
Jessup Wealth Management, Inc 0 500 0.0%